ALBANY, New York — New York's attorney general has announced an agreement with Amphastar Pharmaceuticals to extend a nearly 20 percent price cut for naloxone, an antidote for heroin and other opioid overdoses.
The attorney general's office says Tuesday that Amphastar for another year will cover a $6 rebate per dose, which will also automatically increase, dollar-for-dollar, to match future growth in the wholesale price.
The rebate is available to the state Health Department, New York City and county governments and the drug treatment centers and harm-reduction programs they fund.
In 2013, more than half of New York City's 782 drug-related overdoses were from heroin.
That year, there were almost 20,000 hospitalizations, most to emergency rooms, related to heroin.
Amphastar is based in Rancho Cucamonga, California.